In a new strategic partnership with Salus Optima, IFF are developing a data driven personalized nutrition, health and wellness platform targeting metabolic health
Posted:
1 in 4 adults worldwide are affected by metabolic health issues such as obesity, pre-diabetes, high cholesterol, and pre-hypertension. IFF announced its plans for accelerated entry into the personalized nutrition sector through a strategic partnership with Salus Optima, a British-based, digitally-enabled personalized nutrition, health and wellness company. Read more here.
We are pleased to welcome genedrive as a sponsor and exhibitor at this year’s GIANT Health Event.
Based in Manchester, genedrive is a diagnostics company developing rapid pharmacogenetic testing solutions designed to support safer, more effective prescribing decisions. By helping…
As healthcare systems continue to evolve, ensuring that new technologies deliver real value for patients, professionals, and the wider health and care system is more important than ever.
At GIANT Health, we are pleased to highlight our exhibitor Health Technology…
Attendees
Sponsors and Exhibitors
Contact us